Mark A. Subler

3.8k total citations
65 papers, 3.0k citations indexed

About

Mark A. Subler is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mark A. Subler has authored 65 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 30 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Mark A. Subler's work include Cancer-related Molecular Pathways (20 papers), Cancer Mechanisms and Therapy (14 papers) and Virus-based gene therapy research (9 papers). Mark A. Subler is often cited by papers focused on Cancer-related Molecular Pathways (20 papers), Cancer Mechanisms and Therapy (14 papers) and Virus-based gene therapy research (9 papers). Mark A. Subler collaborates with scholars based in United States, Canada and Japan. Mark A. Subler's co-authors include Sumitra Deb, Daniel W. Martin, Jolene J. Windle, Daniel H. Conrad, Raquel Muñoz, Chunrong Yu, Steven Grant, Mohamed Rahmani, Paul Dent and Doris Brown and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mark A. Subler

65 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark A. Subler 2.0k 1.5k 412 323 268 65 3.0k
Toshiki Mori 1.6k 0.8× 868 0.6× 301 0.7× 137 0.4× 246 0.9× 24 2.4k
S J Ullrich 1.8k 0.9× 1.3k 0.9× 659 1.6× 147 0.5× 269 1.0× 24 2.8k
Daniele Bergamaschi 2.1k 1.1× 1.6k 1.1× 593 1.4× 167 0.5× 151 0.6× 42 3.1k
Mark K. Saville 2.7k 1.3× 1.9k 1.3× 490 1.2× 128 0.4× 152 0.6× 33 3.2k
Laurent Créancier 2.3k 1.2× 1.3k 0.9× 388 0.9× 111 0.3× 233 0.9× 28 3.0k
Elisheva Yonish-Rouach 1.9k 0.9× 1.7k 1.1× 417 1.0× 136 0.4× 230 0.9× 20 2.7k
Anne M. Theodoras 2.5k 1.2× 2.1k 1.4× 399 1.0× 186 0.6× 195 0.7× 8 3.2k
Barbara A. Osborne 2.1k 1.0× 1.7k 1.1× 469 1.1× 144 0.4× 189 0.7× 8 3.0k
Simona Tognin 2.8k 1.4× 1.4k 0.9× 370 0.9× 174 0.5× 175 0.7× 9 3.5k
Francisco M. Barriga 1.1k 0.5× 1.3k 0.9× 469 1.1× 182 0.6× 419 1.6× 29 2.3k

Countries citing papers authored by Mark A. Subler

Since Specialization
Citations

This map shows the geographic impact of Mark A. Subler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Subler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Subler more than expected).

Fields of papers citing papers by Mark A. Subler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Subler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Subler. The network helps show where Mark A. Subler may publish in the future.

Co-authorship network of co-authors of Mark A. Subler

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Subler. A scholar is included among the top collaborators of Mark A. Subler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Subler. Mark A. Subler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kakiyama, Genta, Daniel Rodrı́guez-Agudo, Hajime Takei, et al.. (2025). Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression. Journal of Lipid Research. 66(3). 100757–100757. 1 indexed citations
2.
Miyagawa, Kazuaki, Patrick L. Mulcrone, Jesús Delgado‐Calle, et al.. (2023). Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation. JCI Insight. 8(14). 6 indexed citations
3.
Komaniecki, Garrison, Rachel G. Mendoza, Mark A. Subler, et al.. (2022). Astrocyte Elevated Gene-1 Cys75 S-Palmitoylation by ZDHHC6 Regulates Its Biological Activity. Biochemistry. 62(2). 543–553. 13 indexed citations
4.
Subler, Mark A., et al.. (2021). Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter. Behavioural Brain Research. 408. 113267–113267. 11 indexed citations
5.
Vaughan, Catherine A., Shilpa Singh, Mark A. Subler, et al.. (2021). The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3. Nature Communications. 12(1). 704–704. 18 indexed citations
6.
Robertson, Chadia L., Rachel G. Mendoza, Nidhi Jariwala, et al.. (2018). Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis. Cancer Research. 78(22). 6436–6446. 26 indexed citations
7.
Jariwala, Nidhi, Devaraja Rajasekaran, Rachel G. Mendoza, et al.. (2017). Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma. Cancer Research. 77(12). 3306–3316. 50 indexed citations
8.
Akiel, Maaged, Chunqing Guo, Xia Li, et al.. (2017). IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Research. 77(15). 4014–4025. 50 indexed citations
9.
Menezes, Mitchell E., Xue‐Ning Shen, Swadesh K. Das, et al.. (2015). MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer. Oncotarget. 6(35). 36928–36942. 40 indexed citations
10.
Jiang, Dadi, Catherine I. Dumur, H. Davis Massey, et al.. (2015). Comparison of Effects of p53 Null and Gain-of-Function Mutations on Salivary Tumors in MMTV-Hras Transgenic Mice. PLoS ONE. 10(2). e0118029–e0118029. 4 indexed citations
11.
Robertson, Chadia L., Jyoti Srivastava, Ayesha Siddiq, et al.. (2014). Genetic Deletion of AEG-1 Prevents Hepatocarcinogenesis. Cancer Research. 74(21). 6184–6193. 44 indexed citations
12.
Teves, María E., Richard M. Costanzo, Scott C. Henderson, et al.. (2013). Sperm-Associated Antigen–17 Gene Is Essential for Motile Cilia Function and Neonatal Survival. American Journal of Respiratory Cell and Molecular Biology. 48(6). 765–772. 40 indexed citations
13.
Hawkins, Amy J., Mark A. Subler, Konstantin Akopiants, et al.. (2009). In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation. DNA repair. 8(5). 654–663. 41 indexed citations
14.
Zhang, Baiyu, Mark A. Subler, Jinhua Wu, et al.. (2008). Role of LPA4/p2y9/GPR23 in Negative Regulation of Cell Motility. Molecular Biology of the Cell. 19(12). 5435–5445. 127 indexed citations
15.
Kurihara, Noriyoshi, Yuko Hiruma, Hua Zhou, et al.. (2006). Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. Journal of Clinical Investigation. 117(1). 133–142. 90 indexed citations
16.
Bearss, David J., et al.. (2000). Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors. Oncogene. 19(8). 1114–1122. 36 indexed citations
17.
Subler, Mark A., Elaine Rands, Charles A. Omer, et al.. (1998). A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis. Molecular and Cellular Biology. 18(1). 85–92. 147 indexed citations
18.
Ludes-Meyers, John, Mark A. Subler, Rubén M. Muñoz, et al.. (1996). Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53. Molecular and Cellular Biology. 16(11). 6009–6019. 152 indexed citations
19.
Martin, Daniel W., Raquel Muñoz, David J. Oliver, Mark A. Subler, & Sumitra Deb. (1994). Analysis of the DNA-Binding Domain of the HSV-1 Origin-Binding Protein. Virology. 198(1). 71–80. 23 indexed citations
20.
Martin, Daniel W., et al.. (1993). p53 and SV40 T Antigen Bind to the Same Region Overlapping the Conserved Domain of the TATA-Binding Protein. Biochemical and Biophysical Research Communications. 195(1). 428–434. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiki Mori Breakdown of academic impact, for papers by S J Ullrich Breakdown of academic impact, for papers by Daniele Bergamaschi Breakdown of academic impact, for papers by Mark K. Saville Breakdown of academic impact, for papers by Laurent Créancier Breakdown of academic impact, for papers by Elisheva Yonish-Rouach Breakdown of academic impact, for papers by Anne M. Theodoras Breakdown of academic impact, for papers by Barbara A. Osborne Breakdown of academic impact, for papers by Simona Tognin Breakdown of academic impact, for papers by Francisco M. Barriga
Rankless by CCL
2026